phenylalanine and B-Cell Chronic Lymphocytic Leukemia

phenylalanine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chu, P; Hamada, H; Kato, K; Kipps, TJ; Takahashi, S	1

Other Studies

1 other study(ies) available for phenylalanine and B-Cell Chronic Lymphocytic Leukemia

Article	Year
Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Experimental hematology, 2007, Volume: 35, Issue:3 Topics: CD27 Ligand; Dose-Response Relationship, Drug; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloproteases; Phenotype; Phenylalanine; Protease Inhibitors; Solubility; T-Lymphocytes; Thiophenes; Tumor Necrosis Factor Receptor Superfamily, Member 7	2007

Article

Year

Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.

Experimental hematology, 2007, Volume: 35, Issue:3

Topics: CD27 Ligand; Dose-Response Relationship, Drug; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Metalloproteases; Phenotype; Phenylalanine; Protease Inhibitors; Solubility; T-Lymphocytes; Thiophenes; Tumor Necrosis Factor Receptor Superfamily, Member 7

2007